DRESBUXELIMAB
UNII QR3A4G4VHU

Substance Identification & Data

This profile provides standardized clinical and technical data for Dresbuxelimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QR3A4G4VHU.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2550560-20-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
QR3A4G4VHU
CAS Registry Number
2550560-20-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
DRESBUXELIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C179625
National Cancer Institute reference terminology for clinical and research data.
INN ID
12115
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dresbuxelimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DRESBUXELIMAB

Common Names & Synonyms

AK 119 [WHO-DD]
DRESBUXELIMAB [INN]
IMMUNOGLOBULIN G1, ANTI-(HUMAN 5'-NUCLEOTIDASE) (HUMAN-MUS MUSCULUS MONOCLONAL AK119 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL AK119 .KAPPA.-CHAIN, DIMER

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus